title: Comparison of the efficacies of botulinum toxin A and Johnstone pressure splints against hip adductor spasticity among patients with cerebral palsy: a randomized trial.
abstract: OBJECTIVE
  The goal was to compare the efficacies of botulinum toxin A (BTX) treatment and Johnstone pressure splint (JPS) treatment against hip adductor muscle spasticity among children with spastic diplegic cerebral palsy.
  
  
  METHODS
  For each patient in the BTX group, a total of 300 IU of BTX was injected into adductor and medial hamstring muscle groups. In the JPS group, long leg JPS were administered for 30 minutes 3 days per week. Bobath neurodevelopmental exercises were administered to both groups 3 days per week during the study period. All cases were assessed by using gross motor function measurements, passive hip abduction goniometric measurements, modified Ashworth Scale scores, and measurements of the distance between the knees as indicator variables.
  
  
  RESULTS
  We found that there was statistically significant improvement in all indicators for both groups. BTX treatment was found to be superior to JPS treatment in terms of the indicator variables of our study.
authors.affiliation: Department of Physical Medicine and Rehabilitation, Gulhane Military Medical Academy, Ankara, Turkey.
authors.forename: Bulent
authors.initials: B
authors.lastname: Hazneci
authors.forename: Arif Kenan
authors.initials: AK
authors.lastname: Tan
authors.forename: Mustafa Nuri
authors.initials: MN
authors.lastname: Guncikan
authors.forename: Kemal
authors.initials: K
authors.lastname: Dincer
authors.forename: Tunc Alp
authors.initials: TA
authors.lastname: Kalyon
mesh_terms: D000293:Adolescent; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage / Q000627:therapeutic use*; D002547:Cerebral Palsy / Q000188:drug therapy / Q000503:physiopathology*; D002648:Child; D006621:Hip Joint / Q000187:drug effects / Q000503:physiopathology*; D006801:Humans; D009128:Muscle Spasticity / Q000188:drug therapy* / Q000503:physiopathology; D018482:Muscle, Skeletal / Q000187:drug effects / Q000503:physiopathology; D016059:Range of Motion, Articular; D013165:Splints; D016896:Treatment Outcome
chemical_list: D019274:Botulinum Toxins, Type A